Foundation / Corporation
Epilepsy Foundation - Epilepsy Therapy Project
12/14/18 5:00 PM ET
Awards to USA, Canada, and International individuals for the development of innovative technologies, therapies, or products to treat people with epilepsy. The award will support the development and commercialization of the winner’s product. Examples of concepts eligible for awards include:
-Drug or device treatment that stops a seizure, especially those already developed or approved for a different indication
-System that helps patients manage their treatment or their epilepsy (less invasive, less costly anti-epileptic drug measurement, for example)
-Device that prevents personal injury from a seizure
-Any other concept that could improve the lives of people with epilepsy potentially in the near future
The Shark Tank review committee will select as many as six finalists. All finalists will be invited to present their product concepts or candidates at the 2019 Anti-Epileptic Drug & Device Trials, scheduled for May 22-24, 2019. The winning entry (or entries) will be selected through live voting by conference attendees, and a panel of judges (Sharks) representing physicians and scientists, corporate executives, leading industry investors, people with epilepsy, and advocates. The project(s) deemed to be the most innovative will be announced at the conference, and the winner(s) can receive as much as $200,000 to accelerate the idea towards improving the quality of life of people with epilepsy. All finalists are eligible for a travel stipend to attend the conference and free conference registration.
GrantWatch ID#: 177383
The winner(s) can receive as much as $200,000.
Applicants must demonstrate an ability to move the proposed plan to completion, showing how the prize can accelerate any step along the path to market.
Inventors who submitted ideas for previous Shark Tank Competitions are encouraged to re-submit their ideas if substantial progress has been made.
Applicants may reside in any country. No specific background or experience is required.
The deadline for submitting a Letter of Intent (LOI) is December 14, 2018 at 5:00 PM Eastern Time.
As many as six (6) finalists will be selected to present at the 2019 Anti-Epileptic Drug & Device Trials (Miami, FL, May 22-24, 2019).
Each presenter will have 5 minutes to present the concept, followed by 5 minutes of questioning. The "Shark Tank" event will feature live voting among audience members and a panel of judges (Sharks) representative of industry, advocacy, investors, and the research and medical communities. The winning project, or projects, deemed to be the most innovative will be announced at the conclusion of the competition.
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
Submit LOIs to: email@example.com
8301 Professional Place East, Suite 200
Landover, MD 20785-2353
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
USA Territories: American Samoa (USA) Guam (USA) Puerto Rico (USA) Virgin Islands (USA) Northern Mariana Islands (USA)
USA Compact Free Associations: The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA)
Canada: Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon
International country outside of the USA, Israel and Canada.